JP2024540294A5 - - Google Patents
Info
- Publication number
- JP2024540294A5 JP2024540294A5 JP2024526586A JP2024526586A JP2024540294A5 JP 2024540294 A5 JP2024540294 A5 JP 2024540294A5 JP 2024526586 A JP2024526586 A JP 2024526586A JP 2024526586 A JP2024526586 A JP 2024526586A JP 2024540294 A5 JP2024540294 A5 JP 2024540294A5
- Authority
- JP
- Japan
- Prior art keywords
- human subject
- antibody
- beta
- seq
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163275442P | 2021-11-03 | 2021-11-03 | |
| US63/275,442 | 2021-11-03 | ||
| US202163277127P | 2021-11-08 | 2021-11-08 | |
| US63/277,127 | 2021-11-08 | ||
| US202263309796P | 2022-02-14 | 2022-02-14 | |
| US63/309,796 | 2022-02-14 | ||
| US202263343029P | 2022-05-17 | 2022-05-17 | |
| US63/343,029 | 2022-05-17 | ||
| PCT/US2022/048684 WO2023081194A2 (en) | 2021-11-03 | 2022-11-02 | Methods for treating alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540294A JP2024540294A (ja) | 2024-10-31 |
| JP2024540294A5 true JP2024540294A5 (https=) | 2025-11-12 |
Family
ID=86241855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526586A Pending JP2024540294A (ja) | 2021-11-03 | 2022-11-02 | アルツハイマー病を治療するための方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240425573A1 (https=) |
| EP (1) | EP4426349A4 (https=) |
| JP (1) | JP2024540294A (https=) |
| TW (1) | TW202325728A (https=) |
| WO (1) | WO2023081194A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025240753A1 (en) * | 2024-05-16 | 2025-11-20 | Creative Bio-Peptides, Inc. | Peptides and therapies for treating neurological disorders |
| CN118777453B (zh) * | 2024-06-25 | 2025-04-08 | 上海交通大学医学院附属瑞金医院 | 一种基于液相色谱-串联质谱定量分析血液中仑卡奈单抗浓度的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20140049T1 (hr) * | 2007-01-05 | 2014-02-28 | University Of Zürich | Anti beta-amiloid antitijela i njihova upotreba |
| EP2560681A4 (en) * | 2010-04-22 | 2013-09-25 | Janssen Alzheimer Immunotherap | USE OF TAU FOR MONITORING IMMUNOTHERAPY |
| WO2014011972A1 (en) * | 2012-07-13 | 2014-01-16 | Bristol-Myers Squibb Company | Tau immunoassay |
| NZ630542A (en) * | 2012-08-16 | 2017-06-30 | Ipierian Inc | Methods of treating a tauopathy |
| WO2021016466A1 (en) * | 2019-07-24 | 2021-01-28 | Duke University | Compositions and methods for the diagnosis and treatment of alzheimer's disease |
| KR20220084095A (ko) * | 2019-10-22 | 2022-06-21 | 바이오젠 엠에이 인코포레이티드 | 알츠하이머병의 치료를 위한 항-베타-아밀로이드 항체 |
-
2022
- 2022-11-02 WO PCT/US2022/048684 patent/WO2023081194A2/en not_active Ceased
- 2022-11-02 JP JP2024526586A patent/JP2024540294A/ja active Pending
- 2022-11-02 EP EP22890708.5A patent/EP4426349A4/en active Pending
- 2022-11-02 US US18/707,366 patent/US20240425573A1/en active Pending
- 2022-11-03 TW TW111142020A patent/TW202325728A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022553329A5 (https=) | ||
| Dimachkie et al. | Guillain-Barré syndrome and variants | |
| JP2021169536A (ja) | アルツハイマー病の治療法 | |
| JP2026012271A (ja) | アルツハイマー病を治療するための抗ベータ－アミロイド抗体 | |
| JP2024112859A5 (https=) | ||
| JP2023520516A5 (https=) | ||
| JP2025131566A5 (https=) | ||
| JP2024540294A5 (https=) | ||
| TW202019471A (zh) | 阿茲海默症之治療及預防方法 | |
| US12084491B2 (en) | Treatment of Parkinson's disease | |
| JP7792428B2 (ja) | 抗アミロイドベータ抗体及びその使用 | |
| JP2024525559A5 (https=) | ||
| AU2023208107A1 (en) | Composition comprising an anti-Αβ protofibril antibody and a beta- secretase BACE1 inhibitor for the treatment of Alzheimer's disease | |
| Kaur et al. | Optic neuritis and the neuro‐ophthalmology of multiple sclerosis | |
| JP2025506389A5 (https=) | ||
| Kim et al. | Chronic inflammatory demyelinating polyneuropathy: plasmapheresis or cyclosporine can be good treatment options in refractory cases | |
| JP2023548005A (ja) | 抗トランスサイレチン抗体およびその使用方法 | |
| WO2022090169A1 (en) | Method of safe administration of anti-tau antibody | |
| JP2025540659A (ja) | 抗Ｎ３ｐＧｌｕアミロイドベータ抗体、用量、及びその使用 | |
| CA3266630A1 (en) | Combination treatment of scyllo-inositol and vitamin d and/or other vitamins or active ingredients to treat cognitive disorders | |
| US20240425573A1 (en) | Methods for treating alzheimer's disease | |
| TW202313111A (zh) | 治療阿茲海默症之方法 | |
| Hu | Alzheimer’s disease and treatment: Calcium dyshomeostasis in medial prefrontal cortex pyramidal neurons | |
| Chaudhry et al. | 77. Bortezomib and thalidomide-induced subacute demyelinating polyneuropathy | |
| WO2022251048A1 (en) | Anti-amyloid beta antibodies and uses thereof |